Browse by topic
Subscribe to our blog

Establishing KPIs for your medication adherence program

Are you measuring what matters most for your brand? Many key performance indicators (KPIs) are used to measure the success of adherence programs, and they can vary across different pharmaceutical companies. According to Andrea Kasprzyk, Director of ...
Read

How pharma is advancing medication adherence

We live in exciting times for adherence, and the pharma industry is playing a critical role, according to Mark Degatano, a pharmaceutical industry analytics expert who is on the advisory board of AllazoHealth. Degatano’s expertise comes from 24 ...
Read

Payer quality ratings: 7 best practices

Are you responsible for improving your plan’s quality ratings? Learn how to improve your performance on Star and other quality measures. Download our deck and get specific advice for payers on: The influence of population mix on performance Which ...
Read

4 keys to a successful medication adherence program

With medication non-adherence costing the industry more than $600 billion a year, many pharmaceutical companies are creating medication adherence programs, often in conjunction with pharmacists and payers.
Read

COVID-19: Surveys show payers intensifying patient outreach

What do payers consider as they grapple with the medication access and adherence needs of at-risk patients during the Covid-19 pandemic? Experts at McMann Managed Markets and Syneos Health surveyed their proprietary payer advisory boards to find out.
Read

Optimizing DIR contracts and achieving adherence measures

 
Read

Healthcare AI: Why defining constraints upfront is critical

AllazoHealth COO William Grambley explains in this article: “You need to be explicit about AI program constraints upfront. Otherwise you can get to unintended consequences.”
Read